Edison's EPI-743 reverses progression in Leigh disease trial

Edison Pharmaceuticals Inc. (Mountain View, Calif.) reported data from an open-label Phase IIa trial showing EPI-743 reversed disease progression in 10 children with differing subtypes of Leigh diseas...